| Effect | None |
| Values | 10⁹·L⁻¹. Mean and SEM. At end of supplementation. Placebo: 0.45 ± 0.06 Carnitine: 0.51 ± 0.04 |
| Trial Design | Randomized trial |
| Trial Length | 6+ Months |
| Number of Subjects | 18 |
| Sex | Female |
Eighteen female participants visited the laboratory after 24 weeks of taking 1500 mg of L-carnitine-L-tartrate or isonitrogenous placebo per day. They returned 4 and 12 months after cessation of supplementation for more testing.
The carnitine group saw substantially higher TMAO concentrations by the end of supplementation, which reverted to the placebo levels after 4 months. There weren't statistically significant differences for blood lipids, though. Levels of immune cells weren't statistically significantly different.
